Citation: W. Siegert et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN POOR-RISKGERM-CELL TUMORS, Annals of hematology, 76(5), 1998, pp. 183-188
Authors:
HILDEBRANDT M
BLASER F
BEYER J
SIEGERT W
MAPARA MY
HUHN D
SALAMA A
Citation: M. Hildebrandt et al., DETECTION OF TUMOR-CELLS IN PERIPHERAL-BLOOD SAMPLES FROM PATIENTS WITH GERM-CELL TUMORS USING IMMUNOCYTOCHEMICAL AND REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION TECHNIQUES, Bone marrow transplantation, 22(8), 1998, pp. 771-775
Authors:
SIEGERT W
BEYER J
KINGREEN D
BLASCZYK R
BAURMANN H
SCHWELLA N
SCHLEICHER J
KIRSCH A
HUHN D
Citation: W. Siegert et al., TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH UNMANIPULATED G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELL PREPARATION, Bone marrow transplantation, 22(6), 1998, pp. 579-583
Authors:
SIEGERT W
RICK O
BEYER J
SCHWELLA N
SCHLEICHER J
HUHN D
Citation: W. Siegert et al., CURRENT TREATMENT RESULTS AND FUTURE INDICATIONS FOR HIGH-DOSE CHEMOTHERAPY IN GERM-CELL TUMORS, Bone marrow transplantation, 22, 1998, pp. 15-15
Authors:
BEYER J
KRAMAR A
MANDANAS R
LINKESCH W
GREINIX A
DROZ JP
PICO JL
DIEHL A
BOKEMEYER C
SCHMOLL HJ
NICHOLS CR
EINHORN LH
SIEGERT W
Citation: J. Beyer et al., PROGNOSTIC FACTORS FOR HIGH-DOSE CHEMOTHERAPY (HDCT) AS SALVAGE TREATMENT IN GERM-CELL TUMORS (GCT), Bone marrow transplantation, 22, 1998, pp. 16-16
Authors:
ARNOLD R
BUNJES D
DEEG HJ
EINSELE H
FAUSER AA
FINKE J
HERTENSTEIN B
HEYLL A
KOLB HJ
KOLBE K
MARTIN H
NIEDERWIESER D
SCHAEFER UW
SCHMITZ N
SCHWERDTFEGER R
SIEGERT W
WANDT H
ZANDER A
GOEKBUGET N
HOELZER D
Citation: R. Arnold et al., BMT IN REFRACTORY OR RELAPSED ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES, Bone marrow transplantation, 21, 1998, pp. 2-2
Authors:
RICK O
BEYER J
SCHWELLA N
KINGREEN D
KIRSCH A
SCHLEICHER J
KRUSCH A
HUHN D
SIEGERT W
Citation: O. Rick et al., LONG-TERM SURVIVAL AFTER HIGH-DOSE SALVAGE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL TUMORS, Bone marrow transplantation, 21, 1998, pp. 799-799
Authors:
WILBORN F
BINDER T
NEIPEL F
BLASCZYK R
SIEGERT W
Citation: F. Wilborn et al., HUMAN-HERPESVIRUS TYPE-6 VARIANTS IDENTIFIED BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS, Journal of virological methods, 73(1), 1998, pp. 21-29
Authors:
RICK O
BEYER J
SCHWELLA N
KINGREEN D
KRUSCH A
HUHN D
SIEGERT W
Citation: O. Rick et al., LONG-TERM SURVIVAL AND LATE TOXICITIES AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS SUFFERING FROM GERM-CELL CANCER, European journal of cancer, 33, 1997, pp. 156-156
Authors:
STREMETZNE S
JAEHDE U
KASPER R
BEYER J
SIEGERT W
SCHUNACK W
Citation: S. Stremetzne et al., CONSIDERABLE PLASMA-LEVELS OF A CYTOTOXIC ETOPOSIDE METABOLITE IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY, European journal of cancer, 33(6), 1997, pp. 978-979
Authors:
PONT J
HOLTL W
WEISSBACH L
BEYER J
SIEGERT W
Citation: J. Pont et al., HIGH-DOSE CHEMOTHERAPY AND REINFUSION OF HEMATOPOIETIC STEM-CELLS ADVANCED GERM-CELL TUMORS WITH POOR-PROGNOSIS IN 1996, Der Urologe, 36(6), 1997, pp. 561-564
Authors:
KLEINER S
KIRSCH A
SCHWANER I
KINGREEN D
SCHWELLA N
HUHN D
SIEGERT W
Citation: S. Kleiner et al., HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH RELAPSED OR REFRACTORY MALIGNANT-LYMPHOMAS - A PHASE I II STUDY/, Bone marrow transplantation, 20(11), 1997, pp. 953-959
Citation: D. Kingreen et al., HERPES-SIMPLEX INFECTION OF THE JEJUNUM OCCURRING IN THE EARLY POSTTRANSPLANTATION PERIOD, Bone marrow transplantation, 20(11), 1997, pp. 989-991
Authors:
BEYER J
RICK O
WEINKNECHT S
KINGREEN D
LENZ K
SIEGERT W
Citation: J. Beyer et al., NEPHROTOXICITY AFTER HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE IN GERM-CELL TUMORS - INCIDENCE AND IMPLICATIONS FOR HEMATOLOGIC RECOVERY AND CLINICAL OUTCOME, Bone marrow transplantation, 20(10), 1997, pp. 813-819
Authors:
SCHWELLA N
KINGREEN D
HEUFT HG
OETTLE H
RICK O
SERKE S
HUHN D
SIEGERT W
Citation: N. Schwella et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION DURING HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION, Vox sanguinis, 72(2), 1997, pp. 118-120
Authors:
BEYER J
KINGREEN D
KRAUSE M
SCHLEICHER J
SCHWANER I
SCHWELLA N
HUHN D
SIEGERT W
Citation: J. Beyer et al., LONG-TERM SURVIVAL OF PATIENTS WITH RECURRENT OR REFRACTORY GERM-CELLTUMORS AFTER HIGH-DOSE CHEMOTHERAPY, Cancer, 79(1), 1997, pp. 161-168
Authors:
BEHRE G
SCHWARTZ S
HEINEMANN V
HIDDEMANN W
SIEGERT W
BEYER J
Citation: G. Behre et al., RANDOMIZED TRIAL OF AEROSOL AMPHOTERICIN-B FOR PREVENTION OF INVASIVEASPERGILLUS INFECTIONS IN NEUTROPENIC PATIENTS, Blood, 90(10), 1997, pp. 598-598
Authors:
ENGELHARD M
BRITTINGER G
HUHN D
GERHARTZ HH
MEUSERS P
SIEGERT W
THIEL E
WILMANNS W
AYDEMIR U
BIERWOLF S
GRIESSER H
TIEMANN M
LENNERT K
Citation: M. Engelhard et al., SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - DISTINCTION OF CENTROBLASTIC AND IMMUNOBLASTIC LYMPHOMAS IS A SIGNIFICANT PROGNOSTIC RISK FACTOR, Blood, 89(7), 1997, pp. 2291-2297
Authors:
SCHWELLA N
BEYER J
SCHWANER I
HEUFT HG
RICK O
HUHN D
SERKE S
SIEGERT W
Citation: N. Schwella et al., IMPACT OF PRELEUKAPHERESIS CELL COUNTS ON COLLECTION RESULTS AND CORRELATION OF PROGENITOR-CELL DOSE WITH ENGRAFTMENT AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1114-1121
Authors:
BEYER J
KRAMAR A
MANDANAS R
LINKESCH W
GREINIX A
DROZ JP
PICO JL
DIEHL A
BOKEMEYER C
SCHMOLL HJ
NICHOLS CR
EINHORN LH
SIEGERT W
Citation: J. Beyer et al., HIGH-DOSE CHEMOTHERAPY AS SALVAGE TREATMENT IN GERM-CELL TUMORS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC VARIABLES, Journal of clinical oncology, 14(10), 1996, pp. 2638-2645
Citation: W. Siegert et S. Serke, CYTOKINE MOBILIZED BLOOD CD34-EXPRESSING CELLS ARE NOT CYCLING, Bone marrow transplantation, 17(3), 1996, pp. 467-470
Authors:
AULITZKY WE
NEUBAUER A
KOLBE K
SCHNELLER F
BUSEMANN C
SCHLEIERMACHER E
PESCHEL C
SIEGERT W
HUBER C
HUHN D
Citation: We. Aulitzky et al., PRELIMINARY-RESULTS OF STEM-CELL MOBILIZATION IN CHRONIC MYELOID-LEUKEMIA WITH A MODERATE INTENSITY CHEMOTHERAPY REGIMEN AND G-CSF OR G-CSFPLUS IL-3, Bone marrow transplantation, 17, 1996, pp. 67-69
Authors:
SCHMIDT CA
WILBORN F
WEISS K
BRINKMANN V
OETTLE H
LOHMANN R
LANGREHR JM
NEUHAUS P
SIEGERT W
Citation: Ca. Schmidt et al., A PROSPECTIVE-STUDY OF HUMAN HERPESVIRUS TYPE-6 DETECTED BY POLYMERASE CHAIN-REACTION AFTER LIVER-TRANSPLANTATION, Transplantation, 61(4), 1996, pp. 662-664